Pneumothorax Treatment Market Players:
- Medtronic
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Angiotech
- BetaGlue
- Teleflex Incorporated
- Abbott
- Smith’s Group plc
- ATMOS MedizinTechnik GmbH & Co. KG
- Sinapi Biomedical
- Nobelpharma Co., Ltd
- Vygon
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of pneumothorax treatment is evaluated at USD 34.43 billion.
The global pneumothorax treatment market size exceeded USD 32.89 billion in 2025 and is set to expand at a CAGR of over 5.2%, surpassing USD 54.6 billion revenue by 2035.
North America in the pneumothorax treatment market is projected to hold a 36% share by 2035, impelled by rising chronic lung disease prevalence and advanced healthcare infrastructure.
Key players in the market include Medtronic, Angiotech, BetaGlue, Teleflex Incorporated, Abbott, Smith’s Group plc, ATMOS MedizinTechnik GmbH & Co. KG, Sinapi Biomedical, Nobelpharma Co., Ltd, Vygon.
